Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1698966

registered interest
date	26/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dementia and Parkinson's Disease: Health Services and Social Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure that health and social care professionals are trained in Parkinson’s-related dementia care.
tabling member constituency	Bootle
tabling member printed	Peter Dowd
uin	20658
answer	answer is ministerial correction date of answer 23/04/2024 answer text <p>The standard of training for health care professionals is the responsibility of the health care independent statutory regulatory bodies. They set the outcome standards expected at undergraduate level and approve courses and Higher Education Institutions to write and teach the curricula content that enables their students to meet the regulators outcome standards.</p><p>Whilst not all curricula may necessarily highlight a specific condition, they all nevertheless emphasize the skills and approaches a health care practitioner must develop in order to ensure accurate and timely diagnoses and treatment plans for their patients, including for dementia.</p><p>Individual employers across health and social care are responsible for ensuring their staff are trained and competent to carry out their role, and for investing in the future of their staff by providing continuing professional development (CPD) funding. The required training needs are set out in the Dementia Training Standards Framework, which is available at the following link:</p><p><a href="https://www.skillsforhealth.org.uk/info-hub/dementia-2015-updated-2018/" target="_blank">https://www.skillsforhealth.org.uk/info-hub/dementia-2015-updated-2018/</a></p><p>The framework was commissioned and funded by the Department, and developed in collaboration with the sector. It sets out the essential knowledge, skills, and expected learning outcomes applicable across the health and care spectrum.</p><p>It is applicable to health and social care staff who work with people living with dementia, staff providing direct care and support, and those who provide leadership in transforming care, including social care managers and leaders.</p><p>To supplement local National Health Service employer investment for CPD, the NHS Long Term Workforce Plan, published on 30 June 2023, sets out NHS England’s commitment to continue national CPD funding for nurses, midwives, and allied health professionals. There are a variety of resources available on the NHS England e-learning for health platform, designed to enhance the training and education of the health and social care workforce. This includes a programme on dementia care, and modules in Parkinson’s disease in geriatric medicine.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately grouped question UIN 20624 question first answered 23/04/2024 12:45:10 answering member 4527 label Biography information for Helen Whately
tabling member	4397 label Biography information for Peter Dowd

1698967

registered interest
date	26/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Staff
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when she plans to publish details on how the NHS long-term workforce plan will be implemented.
tabling member constituency	Bootle
tabling member printed	Peter Dowd
uin	20659
answer	answer is ministerial correction date of answer 15/04/2024 answer text <p>We have established a Long Term Workforce Plan Governance Board which will ensure the delivery and review the progress of the Long Term Workforce Plan’s implementation. The modelling NHS England has used in the plan is founded on data, evidence, and analysis and provides a set of broad ranges to measure the potential impact of actions over its 15 year timeframe. We have committed to refreshing the modelling that underpins the plan every two years, or in line with fiscal events.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 20625 question first answered 15/04/2024 08:17:19 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4397 label Biography information for Peter Dowd

1698968

registered interest
date	26/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Parkinson's Disease: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether the NHS Long Term Workforce Plan will include steps to help tackle regional variations in access to Parkinson’s specialist care.
tabling member constituency	Bootle
tabling member printed	Peter Dowd
uin	20660
answer	answer is ministerial correction date of answer 15/04/2024 answer text <p>The NHS Long Term Workforce Plan (LTWP) sets out the steps the National Health Service and its partners need to take to deliver an NHS workforce that meets the changing needs of the population over the next 15 years. It covers the majority of NHS workforce groups, including those working on Parkinson’s disease. The LTWP commits to working closely with systems to consider the best approaches to reviewing the geographical distribution of training posts for wider professional groups.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 20628 question first answered 15/04/2024 08:18:31 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4397 label Biography information for Peter Dowd

1698328

registered interest
date	25/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Rare Diseases: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many appraisals for medicines to treat very rare diseases were started through the National Institute for Health and Care Excellence highly specialised technology programme in each financial year since 2018-19.
tabling member constituency	Bootle
tabling member printed	Peter Dowd
uin	20317
answer	answer is ministerial correction date of answer 15/04/2024 answer text <p>The following table from the National Institute for Health and Care Excellence (NICE) shows the number of highly specialised technology evaluations that started in each year since 2018/2019:</p><table><tbody><tr><td><p>Year</p></td><td><p>Invitations To Participate</p></td></tr><tr><td><p>2018/19</p></td><td><p>4</p></td></tr><tr><td><p>2019/20</p></td><td><p>2</p></td></tr><tr><td><p>2020/21</p></td><td><p>3</p></td></tr><tr><td><p>2021/22</p></td><td><p>7</p></td></tr><tr><td><p>2022/23</p></td><td><p>8</p></td></tr><tr><td><p>2023/24</p></td><td><p>4</p></td></tr><tr><td><p>Total</p></td><td><p>28</p></td></tr></tbody></table><p>Note: The term started has been defined as when the NICE sent the invitation to participate.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 15/04/2024 08:58:55 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4397 label Biography information for Peter Dowd

1698329

registered interest
date	25/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Rare Diseases: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when the National Institute for Health and Care Excellence next plans to review the entry criteria for its highly specialised technologies programme for the evaluation medicines to treat very rare diseases.
tabling member constituency	Bootle
tabling member printed	Peter Dowd
uin	20318
answer	answer is ministerial correction date of answer 15/04/2024 answer text <p>The National Institute for Health and Care Excellence plans to review the criteria for determining whether a medicine should be routed to its highly specialised technologies programme later this year.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 15/04/2024 08:53:57 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4397 label Biography information for Peter Dowd

1694525

registered interest
date	07/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether she has held discussions with NHS England on the need for a dedicated and specific cancer plan.
tabling member constituency	Bootle
tabling member printed	Peter Dowd
uin	17562
answer	answer is ministerial correction date of answer 14/03/2024 answer text <p>The Department works closely with NHS England on a wide range of issues relating to cancer, and to deliver the key priorities on cancer as set out in the NHS Long Term Plan. Current priorities include work on improving cancer survival rates through earlier diagnosis, and reducing cancer treatment waiting times across England, including the time between an urgent general practice referral and the commencement of treatment. The Government is working jointly with NHS England on implementing the delivery plan for tackling the COVID-19 backlogs in elective care, and plans to spend more than £8 billion from 2022/23 to 2024/25 to help drive up and protect elective activity, including cancer diagnosis and treatment activity.</p><p>On 14 August 2023, the Government published a strategic framework for the Major Conditions Strategy to consider the six conditions, including cancer, that contribute most to morbidity and mortality across the population in England. This is because we recognise that most cancer patients will have at least one other condition, so we are developing a Major Conditions Strategy that will include cancer. The Major Conditions Strategy will apply a geographical lens to each condition, to address regional disparities in health outcomes, supporting the levelling up mission to narrow the gap in healthy life expectancy by 2030.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 14/03/2024 17:55:22 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4397 label Biography information for Peter Dowd

1694527

registered interest
date	07/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radiotherapy: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent discussions she has had with Integrated Care Boards in England on replacement programmes for radiotherapy machinery (LINACS); and what mechanisms are in place to allow her Department to oversee the effectiveness of those replacement programmes.
tabling member constituency	Bootle
tabling member printed	Peter Dowd
uin	17563
answer	answer is ministerial correction date of answer 13/03/2024 answer text <p>Since April 2022, the responsibility for investing in new radiotherapy machines has sat with local systems. This is supported by the 2021 Spending Review, which set aside £12 billion in operational capital for the National Health Service, from 2022 to 2025.</p><p>The Government and NHS England are already taking steps to ensure that cancer patients can receive high quality radiotherapy treatment across England. This includes supporting advances in radiotherapy, using cutting-edge imaging and technology to help target radiation doses at cancer cells more precisely.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 13/03/2024 16:09:17 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4397 label Biography information for Peter Dowd

1694528

registered interest
date	07/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radiotherapy: Health Professions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will take steps to recruit an additional 2,000 radiotherapy professionals by 2040.
tabling member constituency	Bootle
tabling member printed	Peter Dowd
uin	17564
answer	answer is ministerial correction date of answer 14/03/2024 answer text <p>In June 2023, NHS England published the NHS Long Term Workforce Plan, which sets out the steps the National Health Service and its partners need to take to deliver a workforce that meets the changing needs of the population, over the next 15 years. The plan recognises the need to increase numbers of allied health professionals (AHPs), including therapeutic and diagnostic radiographers. To address this, we will increase AHP training places from a little over 15,000 in 2021/22 to 17,000 by 2028/89, and then 18,800 by 2031/32, a total increase of approximately 25%. National funding is available to train 150 enhanced practice radiographers a year, to support the diagnosis of cancer and other conditions.</p><p>We have already seen increases in the radiotherapy workforce in NHS trusts and other care organisations in England. In November 2023, there were 894 full-time equivalent (FTE) consultants working in the specialty of clinical oncology, an increase of 40, or 4.6%, since November 2022 and 395, or 79.0%, since November 2010. There are also 3,141 FTE therapeutic radiographers, an increase of 133, or 4.4%, since November 2022 and 1,046, or 50.0%, since November 2010. We are also focused on improving cancer treatment, and are supporting advances in radiotherapy, such as using cutting-edge imaging and technology to help target radiation doses at cancer cells more precisely.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 14/03/2024 13:55:49 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4397 label Biography information for Peter Dowd

1679527

registered interest
date	05/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Patient Choice Schemes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to her Department's guidance entitled Elective recovery taskforce: implementation plan, published on 4 August 2023, what steps she is taking to ensure equity of access for those unable to use digital platforms.
tabling member constituency	Bootle
tabling member printed	Peter Dowd
uin	7964
answer	answer is ministerial correction date of answer 15/01/2024 answer text <p>In September 2023, NHS England published a framework for action on digital inclusion to help the system design and implement inclusive digital approaches and technologies, including actions to build digital skills and capability among patients and National Health Service staff. This covers all NHS digital platforms. Patients unable to use digital channels will continue to be able to access services via telephone and through face-to-face services.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 15/01/2024 14:44:37 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4397 label Biography information for Peter Dowd

1677260

registered interest
date	12/12/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Skin Diseases: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether she is taking steps to monitor the effectiveness of NHS England’s guidance on Referral optimisation for people with skin conditions.
tabling member constituency	Bootle
tabling member printed	Peter Dowd
uin	6510
answer	answer is ministerial correction date of answer 18/12/2023 answer text <p>As advised in the Getting it Right First Time (GIRFT) national report on dermatology, published in August 2021, 56% of trusts reported that they had to wait for commissioner approval before prescribing drugs approved by the National Institute for Health and Care Excellence (NICE), and 12% of trusts said they had been told by clinical commissioning groups that they could not prescribe certain NICE-approved biologics for psoriasis at the time of NHS England’s data questionnaire in 2018/19.</p><p>During GIRFT’s subsequent deep dives into the 110 trusts with significant dermatology activity, it became apparent that there was ongoing variation in the way trusts adopt NICE guidelines. While some allow clinicians to prescribe drugs as soon as they are NICE approved, others have processes in place which can produce delays of more than a year in some cases.</p><p>GIRFT is aiming to publish trust- and system-level data for dermatology on the Model Health System in early 2024, enabling dermatology clinicians and managers to monitor their variation in provision of care, services, and treatments for skin disorders. Specific metrics for inflammatory skin disorders, including biologic prescribing for psoriasis and eczema, will be included. The aim is to use this data to inform the dermatology element of GIRFT’s Further Faster programme to help target unwarranted variation in care provision for inflammatory skin disease. The Further Faster programme supports providers to deliver rapid clinical transformation to reduce 52-week waits.</p><p>There are no plans to introduce specific targets to adopt the NHS England guidance on Referral Optimisation for people with skin conditions. The Outpatient Recovery &amp; Transformation Programme in NHS England will continue to promote the guidance through NHS England regional teams, integrated care boards and directly to provider organisations.</p><p>In addition, specific engagement events, such as the webinar delivered on 21 November 2023, will continue to reinforce the need for appropriate and timely referral optimisation across skin care pathways. The programme is working closely with GIRFT and the Further Faster teams to ensure that referral optimisation is seen as a valuable tool to effectively manage the skin care pathway. Through this effort to engage the system combined with the publication of consistent guidance and evidence across the whole skin care pathway, it is hoped that variation can be reduced, across pathway implementation.</p><p>It should be recognised that there may be appropriate clinical reasons for some regional or local variation, so it is important to ensure that all patients who need specialist skincare have equal access. The programme will look to review data over the course of the year to understand the impact and consider relevant next steps.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 6511 6512 6513 question first answered 18/12/2023 17:11:22 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4397 label Biography information for Peter Dowd